As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.
Chris Bird, Quality Standards Programme Manager, tells us how NICE developed the latest learning disability quality standards
Study will measure public’s preference for different health states
An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).
Draft guidance published today (3 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in final draft guidance published today (26 September 2019).
Operations are set to start taking place in the NHS
Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.
Deborah Duval, the editor of Kidney Matters magazine, tells us how we can enjoy food even on a restricted renal diet
Consultation on priority areas open to stakeholders until mid October
Higher quality evidence would allow NICE to make recommendations on a range of therapies that could help people with tinnitus.
Heidi Livingstone, senior public involvement adviser within NICE's Public Involvement Programme, reflects on the partnership with CMAC
It is estimated that in the UK there are around 30 to 50 children living with the condition
Recruitment for the 2020 intake is open until 28 October 2019
Providing support after a suspected suicide can reduce this risk, especially when tailored to the person’s needs.
It's estimated that 86 people would be eligible for treatment with voretigene neparvovec in England
NICE has today (23 August 2019) announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of cannabidiol for treating 2 types of severe treatment-resistant epilepsy.
Chief executive has been at the helm of the institute since it was founded in April 1999
NICE has today (8 August 2019) published its draft recommendations on the use of cannabis-based medicinal products following a comprehensive evaluation of their clinical and cost-effectiveness.
Another new life-extending treatment for some people with lung cancer is to be made available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (8 August 2019).
NICE has today (7 August 2019) published draft guidance recommending neratinib as an additional treatment for some people with early hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
Aspirin taken daily for 2 years or more could reduce the risk of colorectal cancer in people with Lynch syndrome (LS), says NICE in new draft updated guidance.
NICE has published new draft guidance which aims to improve the wellbeing of adults who provide unpaid care for people over 16 years old.
Kathryn Mason, Head of Hospital Inspection (mental health), discusses the work CQC is undertaking to improve the quality and safety of mental health services
Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.
NICE, BTS and SIGN have today (Wednesday 24 July) announced that future UK-wide guidance for the diagnosis and management of chronic asthma in adults, young people and children will be produced jointly by the three organisations.
Following approval at its recent Board meeting NICE has confirmed the details of its review of the methods it uses to develop guidance on drugs, medical devices and diagnostics.
Newly introduced programme allowed those in hospital to reduce their length of stay by an average of six days
An NHS workforce and resource impact statement published today (17 July 2019) highlights the work being done by national partners to integrate changes recommended by NICE in its updated stroke guideline into routine NHS patient care.
People are being prescribed unnecessarily long courses of antibiotics which may increase their risk of developing antibiotic resistant infections, a study has suggested.
People are being prescribed unnecessarily long courses of antibiotics which may increase their risk of developing antibiotic resistant infections, a study has suggested.
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (17 July 2019).
It’s estimated that around 90,000 people could be eligible for treatment with dapagliflozin
People presenting erythema migrans, the characteristic skin rash associated with Lyme disease, can be diagnosed and treated without the need for blood tests, NICE has said in a final quality standard published today.
The National Institute for Health and Care Excellence (NICE), in collaboration with several other partner organisations, has launched a new initiative to encourage better medicines support for people who are receiving social care services in their homes.
Dacomitinib has been recommended as a first-line treatment option for people with a type of non-small-cell lung cancer (NSCLC), in new NICE guidance.
A handheld device that delivers a small electric current has been recommended by NICE for the prevention and treatment of cluster headaches, a rare but painful type of headache that affects around 100,000 people in the UK.
More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza after NICE today (3 July) published amended draft guidance following a proposal for extending the terms of the managed access agreement (MAA) between NHS England and Biogen for funding it.
Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific Advice team at NICE
NICE has urged local authorities and the public to be aware of the air quality in their homes and to reduce their exposure to indoor pollutants.
People living with dementia should be offered activities such as exercise, aromatherapy, art, gardening, baking, reminiscence therapy, music therapy, mindfulness and animal assisted therapy to help promote their wellbeing.
Consultation on proposal open until Friday 13 September
People with recurrent non-infectious uveitis affecting the back of the eye could benefit from a new treatment option, the fluocinolone acetonide implant, as a result of new NICE guidance published today.
Applications must be received by midday on 19 August 2019
Health Technology Assessment International (HTAi) has announced that NICE has been chosen as co-hosts of their 2021 Annual Meeting.
Jonathan Senker marks Learning Disability Awareness Week
NICE has hosted a parliamentary reception and awards ceremony in celebration of its 20th anniversary.